A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism

NCT01084265 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadism

Interventions

DRUG: Recombinant human luteinizing hormone (r-hLH)
DRUG: Recombinant human follicle-stimulating hormone (r-hFSH)
DRUG: Human chorionic gonadotropin (hCG)

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]